1. Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol

   • Eftychia Demerouti
   • Panagiotis Karyofyllis
   • Vassilios Voudris

   Leading Article 23 January 2019 Pages: 99 - 105

2. How Might Bromodomain and Extra-Terminal (BET) Inhibitors Operate in Cardiovascular Disease?

   • C. Mary Schooling
   • Jie V. Zhao

   Current Opinion 29 January 2019 Pages: 107 - 111

3. Tackling Residual Atherosclerotic Risk in Statin-Treated Adults: Focus on Emerging Drugs

   • Kohei Takata
   • Stephen J. Nicholls

   Review Article 19 December 2018 Pages: 113 - 131

4. Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise

   • Annabella Braschi

   Review Article 04 February 2019 Pages: 133 - 171

   

5. Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine

   • Frédéric Lapostolle
   • Arnoud W. van’t Hof
   • for the ATLANTIC Investigators

   Original Research Article 23 October 2018 Pages: 173 - 183

   

6. Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality

   • Ashley N. Fox
   • Grant H. Skrepnek
   • Toni L. Ripley

   Original Research Article 10 November 2018 Pages: 185 - 193

   

7. Assessment of Non-vitamin K Oral Anticoagulants Use in a Tertiary Care Center in the USA: A Chart Review of 909 Patients

   • Marwan Sheikh-Taha
   • Mary E. Deeb

   Original Research Article 08 November 2018 Pages: 195 - 201

8. Long-Term Effects of Bosentan on Cardiovascular Events in Hispanic Patients with Intermittent Claudication: Four-Year Follow-up of the CLAU Trial

   • Joaquin De Haro
   • Silvia Bleda
   • Francisco Acin

   Original Research Article 12 November 2018 Pages: 203 - 209

   

9. Short-Term Effects of Tolvaptan in Tricuspid Insufficiency Combined with Left Heart Valve Replacement-Caused Volume-Overload Patients: Results of a Prospective Pilot Study

   • Fang Yuan
   • Zhangmin Wu
   • Junjie Zhang

   Original Research Article 25 September 2018 Pages: 211 - 218

   

10. Comment on: “Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials”

    • Prashant B. Rana
    • Nilan T. Jacob
    • Shraddha Bhure

    Letter to the editor 22 February 2019 Pages: 219 - 221

11. Authors’ Reply to Rana et al. “Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials”

    • Usha K. Misra
    • Jayantee Kalita
    • Methil Pradeep

    Letter to the editor 22 February 2019 Pages: 223 - 224

12. Correction to: Plasma Vitamin K₁ Levels in Italian Patients Receiving Oral Anticoagulant Therapy for Mechanical Heart Prosthesis: A Case–Control Study

    • Arturo Cafolla
    • Alessandra Gentili
    • Roberta Curini

    Correction 09 February 2019 Pages: 225 - 225

13. Correction to: FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock

    • Fortunato Senatore
    • Gowraganahalli Jagadeesh
    • Norman Stockbridge

    Correction 01 March 2019 Pages: 227 - 227